Journal profile · PHARMACOLOGY & PHARMACY
Farmacia Hospitalaria
ISSN 1130-6343 · eISSN 2171-8695 · Grupo Aula Médica · Spain
Farmacia Hospitalaria: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.7 (journal website); fully open access; APC about USD 1,640; median 125 days to acceptance (108 articles, last 24 months); 144 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Farmacia Hospitalaria is published by Grupo Aula Médica and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices and Patient Safety and Medication Errors, together about 41.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Farmacia Hospitalaria is a bimonthly journal (6 issues yearly), directed to specialists in hospital pharmacy and to all those interested in pharmacologic therapy.Farmacia Hospitalaria is the official publication of the Sociedad Española de Farmacia Hospitalaria (Spanish Hospital Pharmacy Society, SEFH). It publishes articles in Spanish and English related to pharmacologic therapy and the professional development of the speciality that it represents. Original articles, short articles, and reviews received in Spanish will be translated into English and published in both languages.Farmacia Hospitalaria is an Open Access journal, whose content is available free of charge to users or their institutions. Users are authorised to read, download, copy, distribute, print, search, or link to entire texts of the articles in this journal without prior permission from the editor or author, according to the BOAI definition of Open Access. The papers may be re-used under the terms of the Creative Commons 4.0 license (CC BY-NC-ND). Such use shall be subject to authorisation from SEFH, the journal owner.Farmacia Hospitalaria charges no fees for the submission of papers or publication of articles.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editorial board by country: none in mainland China; most named Spain 29, United States 5, Argentina 4, United Kingdom 2, Taiwan, China 1 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine21%
- Pharmaceutical studies and practicesMedicine11.6%
- Patient Safety and Medication ErrorsHealth Professions9.1%
- Medication Adherence and ComplianceMedicine6%
- Safe Handling of Antineoplastic DrugsHealth Professions5%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.2%
- Antibiotic Use and ResistanceImmunology and Microbiology3.7%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- CiteScore (publisher)
- 1.8Publisher website ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.69LetPub ·
- h-index
- 23OpenAlex ·
- i10-index
- 123OpenAlex ·
- 2-year mean citedness
- 0.83OpenAlex ·
- Self-citation rate
- 23.5%LetPub ·
- Share of gold OA articles
- 65.79%LetPub ·
Volume
- Articles per year
- 90LetPub ·
Articles by year OpenAlex count · 1,463 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 119 | 119 | 11 |
| 2025 | 144 | 144 | 85 |
| 2024 | 152 | 152 | 250 |
| 2023 | 136 | 136 | 329 |
| 2021 | 1 | 1 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
125 daysMedian, submission to acceptance · P25–P75 89 days – 215 days
- Acceptance to online
- median 86 days (108 articles)
- Submission to online
- median 231 days
- Sample
- 108 articles with submission and acceptance dates (203 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 22 weeksLetPub ·
- Submission to first decision
- 14 daysPublisher website ·
- First decision after review
- 57 daysPublisher website ·
- Submission to acceptance
- 95 daysPublisher website ·
- Submission to publication (journal-reported)
- about 55 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,640 | Yes | CC BY-NC-ND | |
| OpenAlex | USD 1,640 / EUR 1,500 / GBP 1,320 / JPY 193,490 | — | — | |
| LetPub | No APC | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Grupo Aula Médica
- Country or region
- Spain
- Language
- English, Spanish
- ISSN
- 1130-6343
- Electronic ISSN
- 2171-8695
- Society / sponsor
- Sociedad Española de Farmacia Hospitalaria
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Farmacia Hospitalaria
What CAS zone is Farmacia Hospitalaria in?
In the 2025 upgraded edition of the CAS Journal Ranking, Farmacia Hospitalaria is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Farmacia Hospitalaria?
The journal's website gives an impact factor of 1.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.8, h-index 23.
How long does peer review take at Farmacia Hospitalaria?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 89–215 days); authors report an average review time of about 22 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Farmacia Hospitalaria based?
Of the 45 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (29), United States (5) and Argentina (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Farmacia Hospitalaria?
According to LetPub and DOAJ records, Farmacia Hospitalaria is indexed in ESCI, Scopus and DOAJ.
Is Farmacia Hospitalaria open access, and what is the APC?
Farmacia Hospitalaria is a fully open-access journal. APC about USD 1,640.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .